New blood vessels surrounding tumours have COX-2 within them (Sano et al, 1995; Chan et al, 1999; Tucker et al, 1999) and, therefore, COX-2 inhibition targets not only the epithelial cells of tumours but also the endothelial cells. The gene discussed is PTGS2; the disease is neoplasm.